Literature DB >> 12607706

Cellular mechanisms of ischemia-reperfusion injury.

H Michael Piper1, Karsten Meuter, Claudia Schäfer.   

Abstract

As of yet, only a few strategies to prevent myocardial reperfusion injury have been tested clinically. In the first minutes of reperfusion, the myocardium can be damaged by contracture development, causing mechanical stiffness, tissue necrosis, and the "stone heart" phenomenon. Reperfusion-induced contracture can have two different causes, namely, Ca2+overload-induced contracture or rigor-type contracture. Ca2+ contracture results from rapid re-energization of contractile cells with a persistent Ca2+ overload. Strategies to prevent this type of injury are directed at cytosolic Ca2+ control or myofibrillar Ca2+ sensitivity. Rigor-contracture occurs when re-energization proceeds very slowly. It does not depend on Ca2+ overload. It may be prevented by strategies improving early mitochondrial reactivation

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12607706     DOI: 10.1016/s0003-4975(02)04686-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  75 in total

1.  Metabolic regulation of sodium-calcium exchange by intracellular acyl CoAs.

Authors:  Michael J Riedel; István Baczkó; Gavin J Searle; Nicola Webster; Matthew Fercho; Lynn Jones; Jessica Lang; Jonathan Lytton; Jason R B Dyck; Peter E Light
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

2.  Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes.

Authors:  Emese Tóth-Zsámboki; Eszter Horváth; Katarina Vargova; Eszter Pankotai; Kanneganti Murthy; Zsuzsanna Zsengellér; Tamás Bárány; Tamás Pék; Katalin Fekete; Róbert Gábor Kiss; István Préda; Zsombor Lacza; Domokos Gerö; Csaba Szabó
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

Review 3.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

4.  Clinical effect of postconditioning in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Authors:  Xian-qing Hu; Jian Cheng; Biao Tang; Zhong-heng Zhang; Ke Huang; Yi-ping Yang; Yan-yan Mao; Ming Zhong; Shen-wen Fu
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

5.  MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.

Authors:  Arin B Aurora; Ahmed I Mahmoud; Xiang Luo; Brett A Johnson; Eva van Rooij; Satoshi Matsuzaki; Kenneth M Humphries; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

Review 6.  Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.

Authors:  Sevil Korkmaz-Icöz; Tamás Radovits; Gábor Szabó
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

7.  Cardiac arrest in athletes and resuscitation.

Authors:  Pramod P Bapat; Anjaneya Bapat; Dhiraj Gupta
Journal:  J Intensive Care Soc       Date:  2015-02-17

8.  Two cases of "stone heart" with fatal outcome.

Authors:  Mathias Hald; Jesper Hønge; Rolf Porskjær Dall; Signe Holm Larsen
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

9.  Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction.

Authors:  Peter E Penson; William R Ford; Emma J Kidd; Kenneth J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

Review 10.  Protective ischaemia in patients: preconditioning and postconditioning.

Authors:  Asger Granfeldt; David J Lefer; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2009-04-27       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.